Opioid Treatment for Adults With and Without Systemic Autoimmune/Inflammatory Rheumatic Diseases: Analysis of 2006–2019 United States National Data
Main finding · Opioid prescribingResult — go to the resultAdjusted odds ratio 2.65 95% CI 1.68–4.18Authors' conclusion
Opioid prescribing in SARDs was higher compared to non-SARDs.
Study context
- Population
- Adult (≥18 years) ambulatory visits, National Ambulatory Medical Care Survey, US, 2006–2019annual average visits: 5.20 million systemic autoimmune/inflammatory rheumatic diseases (SARDs), 780.14 million non-SARDs
- Exposure
- Ambulatory visits with SARDs vs without SARDs
- Outcome
- Opioid prescribing
Methodological detailsmultivariable logistic regression accounting for complex survey design, adjusted for predisposing, enabling and need factors (Andersen's Behavioral Model)
- Multivariable logistic regression accounting for complex survey design
- Adjusted for predisposing, enabling and need factors (Andersen's Behavioral Model)
Main finding
As reported in the abstract
Adjusted odds ratio
2.65
95% CI 1.68–4.18
By group
SARDsvs non-SARDs
aOR 2.65 (95% CI 1.68–4.18)
Observational data: associations, not effects.
Further findings
| Outcome | aOR (95% CI) | |
|---|---|---|
| Predictors of opioid prescribing among SARDs visitsAge 50 to 64vs Ages 18-49 | 1.95 (1.05–3.65) | |
| Predictors of opioid prescribing among SARDs visitsPrivate insurancevs Medicare | 0.50 (0.31–0.82) | |
| 0.20.5125Adjusted odds ratio (log scale) |
Predictors of opioid prescribing among SARDs visits
| aOR (95% CI) | ||
|---|---|---|
| GC prescribing | 1.75 (1.20–2.54) | |
| 0.20.5125Adjusted odds ratio (log scale) |
Original publication
Opioid Treatment for Adults With and Without Systemic Autoimmune/Inflammatory Rheumatic Diseases: Analysis of 2006–2019 United States National Data. Arthritis Care Res (Hoboken). Published 17 June 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →